Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antithrombin III levels in preeclampsia.

E Aghai1, J Brunstein, M Quitt

  • 1Institute of Hematology, Lady Davis Carmel Hospital, Haifa, Israel.

Israel Journal of Medical Sciences
|March 1, 1990
PubMed
Summary

Preeclampsia is linked to lower Antithrombin III (AT-III) levels, particularly with significant proteinuria. Urinary protein loss is the primary cause of reduced AT-III activity in these patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A simple index predicting mortality in acutely hospitalized patients.

QJM : monthly journal of the Association of Physicians·2020
Same author

The effect of a structured personalized ergonomic intervention program for hospital nurses with reported musculoskeletal pain: An assigned randomized control trial.

Work (Reading, Mass.)·2016
Same author

Autovalidation rates in an outpatient coagulation laboratory.

International journal of laboratory hematology·2015
Same author

Acute leukemia detection rate by automated blood count parameters and peripheral smear review.

International journal of laboratory hematology·2014
Same author

Do worker's chronically exposed to lead have leukocytosis?

Work (Reading, Mass.)·2014
Same author

The effect of exposure to SO2 on the respiratory system of power-station workers.

Work (Reading, Mass.)·2014

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Nephrology

Background:

  • Preeclampsia is a serious pregnancy complication characterized by high blood pressure and potential organ damage.
  • Antithrombin III (AT-III) is a crucial protein that regulates blood clotting.
  • Reduced AT-III levels have been observed in preeclampsia, but the underlying mechanisms require further clarification.

Purpose of the Study:

  • To compare Antithrombin III (AT-III) activity in preeclamptic patients versus normal pregnancies.
  • To investigate the relationship between proteinuria severity and AT-III levels in preeclampsia.
  • To identify factors influencing AT-III levels in preeclamptic pregnancies.

Main Methods:

  • Antithrombin III (AT-III) activity was measured in 29 preeclamptic patients and 31 healthy pregnant women.
  • Proteinuria levels were quantified and categorized.
  • Multivariate analysis was employed to assess the impact of pregnancy duration and proteinuria on AT-III levels.

Main Results:

  • AT-III levels were significantly lower (83 +/- 25%) in preeclamptic patients with proteinuria >5 g/l compared to controls (102 +/- 11%).
  • Mild proteinuria did not correlate with decreased AT-III activity.
  • Both pregnancy duration and the degree of proteinuria independently reduced AT-III levels.

Conclusions:

  • Urinary protein loss is identified as the primary mechanism for diminished AT-III levels in preeclampsia.
  • AT-III levels show a poor correlation with platelet counts and blood pressure in this cohort.
  • Monitoring AT-III activity in relation to proteinuria may be valuable in managing preeclampsia.

Related Experiment Videos